0001213900-23-092817.txt : 20231204 0001213900-23-092817.hdr.sgml : 20231204 20231204172813 ACCESSION NUMBER: 0001213900-23-092817 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patane Michael A CENTRAL INDEX KEY: 0002002987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 231464460 MAIL ADDRESS: STREET 1: 6 WESTWIND ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2023-12-01 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0002002987 Patane Michael A 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 1 0 0 0 0 Stock Options (Right to Buy) 0.36 2023-12-01 4 A 0 132442 0 A 2024-12-01 2033-12-01 Common Stock 132442 132442 D The options vest and first become exercisable in 36 equal monthly installments, with the first installment vesting on December 1, 2024 and the remaining installments on the 1st of the month for the next 35 months. /s/ Michael A Patane 2023-12-01